+117.4%
DINO vs GSK
+22.9%
+94.5%
-17.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | -1.0% | +0.7% | -0.6% |
| 7D | +1.5% | -5.4% | +6.9% | +0.3% |
| 30D | +25.9% | -4.6% | +30.5% | +24.7% |
| 3M | +53.2% | -5.1% | +58.3% | +51.6% |
| 6M | +105.5% | -11.4% | +116.9% | +101.3% |
| YTD | +139.2% | +0.7% | +138.5% | +130.7% |
| 1Y | +117.4% | +23.0% | +94.4% | +110.7% |
| All | +117.4% | +22.9% | +94.5% | +110.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling